Seven New Insulin Products to be Locally Produced in Saudi Arabia
Saudi Arabia signed an agreement to produce at least seven insulin products locally, enhancing its pharmaceutical capabilities and supporting Vision 2030's goals for health security.
Oct 24, 2024
On Tuesday, Saudi Arabia signed an agreement to localize at least seven insulin products. The ceremony took place during the Global Health Exhibition in Riyadh and was attended by notable figures, including Minister of Health Fahad Al-Jalajel, Minister of Investment Khalid Al-Falih, and Minister of Industry and Mineral Resources Bandar Alkhorayef.
This agreement was forged in collaboration with the National Unified Procurement Company for Medical Supplies (NUPCO), Sudair Pharmaceutical Company, Sanofi, and Novo Nordisk. It underscores Saudi Arabia's commitment to boosting local production capabilities while fostering an attractive investment climate, in alignment with the goals set out in Saudi Vision 2030.
The initiative aims to bolster efforts by government agencies, including the Ministries of Health, Investment, and Industry and Mineral Resources, to localize the medical and pharmaceutical sectors. This move aims to achieve drug and health security in the Kingdom while ensuring that domestic pharmaceutical needs and requirements are met effectively.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Mid East Info
a day ago
- Mid East Info
Abu Dhabi Reinforces Global Leadership in Healthcare Innovation with High-Level U.S. Visit - Middle East Business News and Information
Strategic mission to the U.S. aims to strengthen partnerships and showcase Abu Dhabi's excellence in life sciences and precision medicine Abu Dhabi, United Arab Emirates – June 2025: A high-level delegation led by the Department of Health – Abu Dhabi (DoH), is set to embark on a strategic mission to the United States from June 14 to 21, 2025. The visit reaffirms Abu Dhabi's global leadership in healthcare innovation and reflects its broader vision for healthcare transformation—driven by innovation, investment, and a deep commitment to global collaboration. The delegation will visit key U.S. cities including Boston, Washington D.C., and Philadelphia, in parallel with Abu Dhabi's participation at BIO International Convention 2025 , one of the world's foremost biotechnology events. The visit will spotlight the Emirate's achievements in AI, digital health, genomics, and clinical research and showcase Abu Dhabi's Health, Endurance, Longevity and Medicine (HELM) Life Science Cluster, while promoting long-term strategic partnerships with government entities, research institutions, and global innovators. H.E. Dr. Noura Khamis Al Ghaithi, Undersecretary of the Department of Health – Abu Dhabi, stated: 'This mission reflects our commitment to shaping the future of health through collaboration, innovation, and shared purpose. Our vision is to build a health system that predicts, prevents, acts to restore, and acts to cure, therefore ensuring better outcomes for our communities and beyond. This can only be achieved through meaningful partnerships and a shared ambition to improve lives. We are proud to join our partners in the United States to explore new opportunities that advance healthcare, both in the UAE and globally.' The delegation will conduct over 20 strategic meetings and visits with public and private sector leaders across the U.S., aimed at knowledge exchange, investment opportunities, and the signing of new agreements that accelerate the adoption of advanced health solutions. Representing Abu Dhabi's innovation ecosystem, the delegation includes key stakeholders such as the Abu Dhabi Investment Office, Mubadala BIO, M42, Masdar City, KEZAD, PureHealth, and Etihad Cargo. Abu Dhabi continues to lead the region in genomics through the Emirati Genome Programme, which has successfully sequenced over 800,000 samples, creating one of the most advanced national genomic databases. The Emirate is also home to more than 90 licensed research centers and 30+ ongoing clinical trials in areas such as oncology, rare diseases, and chronic conditions. Advanced data platforms such as Malaffi, which securely store over 5 million patient records—enable AI-powered insights and real-world evidence, while national initiatives like the Golden Visa program are cultivating a global workforce and have granted over 2,000 long-term visas for researchers and healthcare professionals from around the world.
Mid East Info
04-06-2025
- Mid East Info
KFSHRC Pioneering Clinical Trials and Gene Therapy Across the Region - Middle East Business News and Information
As part of Saudi Arabia's broader biotechnology transformation under Vision 2030, King Faisal Specialist Hospital & Research Centre (KFSHRC) solidified its role as the Kingdom's leading Clinical Trials hub in 2024 — conducting 52.4% of all active Clinical Trials nationwide, according to the Saudi National Institute of Health. This milestone reflects the sustained success of KFSHRC's Clinical Trials Transformation Initiative, launched in 2021 to build an integrated, patient-centered research ecosystem. By the end of 2024, the hospital had recorded 701 active research proposals, representing an 8% increase over the previous year. In Riyadh alone, research approvals rose by 20%, demonstrating growing alignment between scientific discovery and clinical care delivery. KFSHRC's research growth was matched by key innovation milestones. In 2024, it became the first in Saudi Arabia to locally produce CAR-T cells — a major step toward national self-sufficiency in advanced therapies. It also delivered a breakthrough in hemophilia care, using one-time gene therapy to restore clotting function in eight patients, eliminating preventive treatment and significantly improving quality of life. These advancements align closely with Saudi Arabia's Vision 2030 and National Biotechnology Strategy, which designate biotechnology as a national priority sector — aiming to localize therapeutic development, accelerate innovation, and establish global leadership by 2040. Complementing its scientific leadership, KFSHRC has also invested in public engagement, launching awareness campaigns in high-traffic public venues to promote Clinical Trials literacy and reduce misconceptions around participation. It is noteworthy that KFSHRC has been ranked first in the Middle East and Africa and 15th globally among the world's top 250 Academic Medical Centres for the third consecutive year, and recognised as the most valuable healthcare brand in the Kingdom and the Middle East, according to the 2025 Brand Finance rankings. Additionally, it was included in the World's Best Smart Hospitals list for 2025 by Newsweek magazine.
Mid East Info
03-06-2025
- Mid East Info
UAE startup makes waves with free mineral water for everyone - Middle East Business News and Information
Staying hydrated just got easier, and greener, thanks to Ourwatr, a homegrown UAE startup that's launching a nationwide free mineral water programme starting June 2025. It's a first in the region: clean, refreshing mineral water made freely available across the country, delivered through a unique model that blends sustainability, community care, and social impact. From metro stations and shopping malls to parks and government offices, thousands of chilled bottles of mineral water, sourced locally from Dibba, Fujairah, will soon be within everyone's reach, every day. Ourwatr's mission is simple: hydration is a right, not a privilege. 'At Ourwatr, we believe that drinking water should be accessible to all,' says Abhinav Murali, Co-founder. 'That's why we're giving away premium mineral water for free, and every bottle supports communities in need. It's hydration with heart, proudly made right here in the UAE.' Stamp of UAE quality All Ourwatr bottles carry the prestigious EQM (Emirates Quality Mark) certification, guaranteeing they meet strict UAE national and international quality standards. When you grab a bottle, you're assured of top-quality water, safe, pure, refreshing and approved by the country's standardisation authority. Mission in a bottle With temperatures rising across the UAE, especially during summer, access to clean drinking water is more important than ever, for workers, families, children, and the elderly alike. 'In our desert climate, hydration isn't just healthy; it's life-saving,' adds co-founder Bharath Mohan. 'Each bottle we provide is a small act of kindness toward our community.' Ourwatr is more than just a startup, it's a mission in a bottle. Launched by three young, UAE-based entrepreneurs, the idea was sparked by a simple but powerful observation: access to free, convenient hydration isn't always a given. Wanting to change that, the trio built a business with heart at its core. The team is also in talks with various UAE charitable organisations and government agencies to expand its reach and impact. For every bottle distributed, a portion will be donated to local charities, turning everyday hydration into a meaningful act of giving. A Model Built on Purpose and Sustainability Ourwatr isn't just about water, it's about doing good. Instead of selling to consumers, the company partners with brands and organisations who cover the production and distribution costs. In return, sponsors co-brand the bottles, using them as a platform to share positive messages and shared values, while making a real difference. 'Sustainability isn't just about less waste, it's about creating lasting, meaningful change,' explains Sharat Nair, Co-founder. The bottles are crafted from recyclable materials, aligning with the UAE's zero-waste goals and green agenda. Backing UAE Vision 2030 Ourwatr's initiative supports the UAE's Vision 2030 goals around health, sustainability, and quality of life. The startup is already collaborating with local authorities to expand water access and reach as many people as possible. More than just water, Ourwatr is delivering hope, equality, and care, one bottle at a time.
